Data / Form D filings / Efemoral Medical, Inc.
Efemoral Medical, Inc.: Form D filings
Efemoral Medical, Inc., a biotechnology company in Los Altos, CA, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on June 16, 2023, reports $525,000 sold of a $3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2300 DEODARA DRIVE, Los Altos, CA, 94024
- Phone
- (408) 718-1472
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1758320
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | New notice | $3,000,000 | $525,000 | $2,475,000 | 2 | Jun 12, 2023 | sec.gov |
| Nov 28, 2022 | New notice | $7,569,360 | $3,190,000 | $4,379,360 | 15 | May 30, 2022 | sec.gov |
| Nov 16, 2018 | New notice | $2,000,000 | $1,010,000 | $990,000 | 20 | Nov 8, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Haig | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 12, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Efemoral Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.